These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

40 related articles for article (PubMed ID: 10843685)

  • 1. M cell-targeted DNA vaccination.
    Wu Y; Wang X; Csencsits KL; Haddad A; Walters N; Pascual DW
    Proc Natl Acad Sci U S A; 2001 Jul; 98(16):9318-23. PubMed ID: 11459939
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Therapeutic Efficacy of Delta-Like Ligand 4 Gene Vaccine Overexpression on Liver Cancer in Mice.
    Yu Y; Zhao Y; Zhou G; Wang X
    Technol Cancer Res Treat; 2020; 19():1533033820942205. PubMed ID: 33191858
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Polyethylenimine-based micro/nanoparticles as vaccine adjuvants.
    Shen C; Li J; Zhang Y; Li Y; Shen G; Zhu J; Tao J
    Int J Nanomedicine; 2017; 12():5443-5460. PubMed ID: 28814862
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recent trends on hydrogel based drug delivery systems for infectious diseases.
    Vashist A; Kaushik A; Vashist A; Jayant RD; Tomitaka A; Ahmad S; Gupta YK; Nair M
    Biomater Sci; 2016 Oct; 4(11):1535-1553. PubMed ID: 27709137
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Self-enhanced targeted delivery of a cell wall- and membrane-active antibiotics, daptomycin, against staphylococcal pneumonia.
    Jiang H; Xiong M; Bi Q; Wang Y; Li C
    Acta Pharm Sin B; 2016 Jul; 6(4):319-28. PubMed ID: 27471672
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nanocarrier mediated delivery of siRNA/miRNA in combination with chemotherapeutic agents for cancer therapy: current progress and advances.
    Gandhi NS; Tekade RK; Chougule MB
    J Control Release; 2014 Nov; 194():238-56. PubMed ID: 25204288
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biodistribution and renal clearance of biocompatible lung targeted poly(ethylene glycol) (PEG) nanogel aggregates.
    Deshmukh M; Kutscher HL; Gao D; Sunil VR; Malaviya R; Vayas K; Stein S; Laskin JD; Laskin DL; Sinko PJ
    J Control Release; 2012 Nov; 164(1):65-73. PubMed ID: 23041417
    [TBL] [Abstract][Full Text] [Related]  

  • 8. GM-CSF in the lung protects against lethal influenza infection.
    Huang FF; Barnes PF; Feng Y; Donis R; Chroneos ZC; Idell S; Allen T; Perez DR; Whitsett JA; Dunussi-Joannopoulos K; Shams H
    Am J Respir Crit Care Med; 2011 Jul; 184(2):259-68. PubMed ID: 21474645
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vaccination strategies to enhance local immunity and protection against Mycobacteriun tuberculosis.
    Klucar P; Barnes PF; Kong Y; Howard ST; Pang X; Huang FF; Tvinnereim AR; Samten B; Shams H
    Vaccine; 2009 Mar; 27(12):1816-24. PubMed ID: 19402204
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mucosal immunity: overcoming the barrier for induction of proximal responses.
    McKenzie BS; Brady JL; Lew AM
    Immunol Res; 2004; 30(1):35-71. PubMed ID: 15258310
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Delivery systems for pulmonary gene therapy.
    Gautam A; Waldrep CJ; Densmore CL
    Am J Respir Med; 2002; 1(1):35-46. PubMed ID: 14720074
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmaceutical strategies utilizing recombinant human serum albumin.
    Chuang VT; Kragh-Hansen U; Otagiri M
    Pharm Res; 2002 May; 19(5):569-77. PubMed ID: 12069157
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nucleic acid vaccines: tasks and tactics.
    McKenzie BS; Corbett AJ; Brady JL; Dyer CM; Strugnell RA; Kent SJ; Kramer DR; Boyle JS; Lew AM
    Immunol Res; 2001; 24(3):225-44. PubMed ID: 11817323
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metabolic biotinylation of recombinant proteins in mammalian cells and in mice.
    Parrott MB; Barry MA
    Mol Ther; 2000 Jan; 1(1):96-104. PubMed ID: 10933917
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genetic immunization with lung-targeting macroaggregated polyethyleneimine-albumin conjugates elicits combined systemic and mucosal immune responses.
    Orson FM; Kinsey BM; Hua PJ; Bhogal BS; Densmore CL; Barry MA
    J Immunol; 2000 Jun; 164(12):6313-21. PubMed ID: 10843685
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Induction of gp120-specific protective immune responses by genetic vaccination with linear polyethylenimine-plasmid complex.
    Garzón MR; Berraondo P; Crettaz J; Ochoa L; Vera M; Lasarte JJ; Vales A; Van Rooijen N; Ruiz J; Prieto J; Zulueta J; González-Aseguinolaza G
    Vaccine; 2005 Feb; 23(11):1384-92. PubMed ID: 15661387
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Functional equivalency of B7-1 and B7-2 for costimulating plasmid DNA vaccine-elicited CTL responses.
    Santra S; Barouch DH; Jackson SS; Kuroda MJ; Schmitz JE; Lifton MA; Sharpe AH; Letvin NL
    J Immunol; 2000 Dec; 165(12):6791-5. PubMed ID: 11120800
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intranasal immunization with plasmid DNA-lipid complexes elicits mucosal immunity in the female genital and rectal tracts.
    Klavinskis LS; Barnfield C; Gao L; Parker S
    J Immunol; 1999 Jan; 162(1):254-62. PubMed ID: 9886393
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intradermal naked plasmid DNA immunization: mechanisms of action.
    Elnekave M; Furmanov K; Hovav AH
    Expert Rev Vaccines; 2011 Aug; 10(8):1169-82. PubMed ID: 21854310
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.